Nadim Salomon, MD
img_Nadim Salomon
PROFESSOR | Medicine, Infectious Diseases
Are you a patient?
Specialties
Infectious Disease, Internal Medicine
New topic

My main scientific interest interests have been in the fields of HIV and HIV-related opportunistic infections. I have made important contributions towards improved therapies for acyclovir-resistant mucocutaneous herpes simplex infection and cryptococcal meningitis and towards the description of clinical features and risk factors of invasive aspergillosis and CMV pneumonia.  I have made major contributions to the field of tuberculosis including the design and implementation of TB screening in needle exchange attendees and of directly observed outpatient TB and HIV treatment, the association of early identification of MDR-TB and DOT with improved MDRT-TB outcomes in both HIV negative and HIV positive patients, and the critical role of HIV-related immune suppression rather than resistance per se in HIV-TB mortality.  My research have not only informed the conduct of TB DOT in New York City but also the design of several national multicenter studies including ACTG 222 (Treatment of Pulmonary TB in HIV-infected persons), ACTG 309 (PK of antituberculosis agents in HIV infected patients), ACTG 5073 (Utility of outpatient DOT) in HIV.  I have collaborated with several agencies/institutions (CDC, NYC Health Department, Columbia University, New York University, TB Trials Consortium, NYC Tuberculosis Group) on study projects towards improving therapies for HIV-TB and adherence to HIV antiretroviral therapies, epidemiology of TB resistance, and interventions to reduce substance abuse in HIV infected persons (see CV).  I have served as a research mentor for 25 residents and fellows; their research findings have been published at national and nternational conferences (see CV).  My research will continue to focus on improved treatment outcomes in HIV and Hepatitis C and I will continue to serve as a mentor for students, residents and fellows.

 

MD, University Of Haiti

Residency, Internal Medicine, Lincoln Medical & Mental Health Center

Fellowship, Infectious Disease, Mount Sinai Beth Israel

Certifications

American Board of Internal Medicine

2016

New York City Super Doctor

NYT2016

2015

New York City Super Doctor

NYT 2015

2014

New York City Super Doctor

NYT 2014

2012

New York Super Doctor

NYT 2012

2011

New York Super Doctor

NYT, 2011

2010

New York City Super Doctor

NYT, 2010

2010

Top Doctor in NY, International Association of Internists, The Leading Physicians of the World

2009

New York City Super Doctor

NYT, 2009

1998

Fellow

Infectious Diseases Society of America

1993 Teacher of the year - can be nominated only once

Beth Israel Society for the Teaching of Medicine

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Below are financial relationships with industry reported by Dr. Salomon during 2023 and/or 2024. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting or Other Professional Services: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership

  • VIIV

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.